SG11201805430PA - Nkt cell-activation pharmaceutical composition, method for producing thereof and method of storing antigen presenting cell - Google Patents

Nkt cell-activation pharmaceutical composition, method for producing thereof and method of storing antigen presenting cell

Info

Publication number
SG11201805430PA
SG11201805430PA SG11201805430PA SG11201805430PA SG11201805430PA SG 11201805430P A SG11201805430P A SG 11201805430PA SG 11201805430P A SG11201805430P A SG 11201805430PA SG 11201805430P A SG11201805430P A SG 11201805430PA SG 11201805430P A SG11201805430P A SG 11201805430PA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
cell
storing
producing
antigen presenting
Prior art date
Application number
SG11201805430PA
Other languages
English (en)
Inventor
Shinichiro Motohashi
Motohiro Harai
Original Assignee
Fuji Soft Incorporated
Univ Chiba Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Soft Incorporated, Univ Chiba Nat Univ Corp filed Critical Fuji Soft Incorporated
Publication of SG11201805430PA publication Critical patent/SG11201805430PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464402—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201805430PA 2015-12-25 2016-12-22 Nkt cell-activation pharmaceutical composition, method for producing thereof and method of storing antigen presenting cell SG11201805430PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015254533A JP6779616B2 (ja) 2015-12-25 2015-12-25 Ｎｋｔ細胞活性化医薬組成物、その製造方法、及び抗原提示細胞の保存方法
PCT/JP2016/088561 WO2017111124A1 (ja) 2015-12-25 2016-12-22 Ｎｋｔ細胞活性化医薬組成物、その製造方法、及び抗原提示細胞の保存方法

Publications (1)

Publication Number Publication Date
SG11201805430PA true SG11201805430PA (en) 2018-07-30

Family

ID=59090495

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805430PA SG11201805430PA (en) 2015-12-25 2016-12-22 Nkt cell-activation pharmaceutical composition, method for producing thereof and method of storing antigen presenting cell

Country Status (5)

Country Link
US (1) US20180296655A1 (ja)
EP (1) EP3395349A4 (ja)
JP (1) JP6779616B2 (ja)
SG (1) SG11201805430PA (ja)
WO (1) WO2017111124A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475196B (zh) * 2017-10-09 2018-07-20 天津长和生物技术有限公司 自然杀伤细胞培养基质及自然杀伤细胞的扩增培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160045151A (ko) * 2005-04-08 2016-04-26 아르고스 쎄라퓨틱스 인코포레이티드 수지상 세포 조성물 및 방법
DE102005031532A1 (de) * 2005-07-01 2007-01-04 Cytonet Gmbh & Co. Kg Lagermedium für Zellen
EP2776558A4 (en) * 2011-11-11 2015-04-08 Essential Pharmaceuticals Llc KIT WITH SERUMERATION AND LABILITY FACTORS
US10022401B2 (en) * 2014-02-26 2018-07-17 National University Corporation Hokkaido University Pharmaceutical containing dendritic cells, and method for producing same

Also Published As

Publication number Publication date
US20180296655A1 (en) 2018-10-18
EP3395349A4 (en) 2019-07-17
JP6779616B2 (ja) 2020-11-04
WO2017111124A1 (ja) 2017-06-29
EP3395349A1 (en) 2018-10-31
JP2017114828A (ja) 2017-06-29

Similar Documents

Publication Publication Date Title
CY1121843T1 (el) Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου
AU2016204248A1 (en) Boron-Containing Molecules
MX2017017095A (es) Cartucho para un sistema generador de aerosol.
PH12015500115B1 (en) Glucagon analogues
AU2015329974A8 (en) GaINAc phosphoramidites, nucleic acid conjugates thereof and their use
BR112016010209A2 (pt) recipientes flexíveis e métodos para a produção dos mesmos
MX2014009256A (es) Dispositivos de recogida de muestras con agentes de estabilizacion sanguinea.
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
BR112015019636A2 (pt) recipiente e dispensador de raspadores dentais
MX361338B (es) Espuma quimica que se remueve con enjuague que contiene peroxido de benzoilo.
BR112016023620A2 (pt) frasco, sistema que compreende tal frasco e método para produção do mesmo
MX2016012360A (es) Espuma quimica sin enjuague que comprende peroxido de benzoilo.
CL2014003429A1 (es) Compuestos especificos derivados de indanosulfamida; composicion farmaceutica que los comprende, utiles en el tratamiento e la epilepsia.
CY1118461T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν αναστολεα αρωματασης
NZ735362A (en) Lipid compositions
NZ731103A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MX2022006304A (es) Composiciones y metodos para inhibir la actividad biologica de biomoleculas solubles.
MX2019002699A (es) Terapia genica para pacientes con anemia de fanconi.
BR112016006171A2 (pt) formulações de espuma e dispositivo para sua entrega
MX2022003399A (es) Metodo basado en celulas para determinar la potencia de la defibrotida.
MX2018006226A (es) Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo.
EP3111945A4 (en) Pharmaceutical containing dendritic cells, and method for producing same
SG11201805430PA (en) Nkt cell-activation pharmaceutical composition, method for producing thereof and method of storing antigen presenting cell
MX2018001221A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.